News1 min read
Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentation at American Society of Hematology (ASH) Annual Meeting
Beam Therapeutics is set to present updated clinical data from the BEACON Phase 1/2 trial of Risto-cel in sickle cell disease at the American Society of Hematology Annual Meeting…
About this article
- Published
- Last updated
- Further reading
- Yahoo Finance(opens in a new tab)
